COMMUNIQUÉS West-GlobeNewswire

NuLife Announces Merger Agreement with Two Louisiana Electronic Security Firms
09/08/2018
NEWPORT BEACH, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- NuLife Sciences, Inc. (OTCQB: “NULF”) announced today that it has entered into a definitive merger agreement to acquire LJR Security Services, Inc. (“LJR”) and [...]
Key Biologics and Astarte Biologics Merge
09/08/2018
Includes growth equity investment from Ampersand Capital Partners MEMPHIS, Tenn. and BOTHELL, Wash., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Key Biologics , has completed its merger with Astarte Biologics to create the [...]
Nemaura Medical Inc. Reports First Quarter 2018 Financial Results
09/08/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today reported [...]
electroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-Invasive Vagus Nerve Stimulation in Neuroinflammation
09/08/2018
BASKING RIDGE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a research collaboration with Massachusetts General Hospital ( [...]
Clearside Biomedical to Participate in 2018 Wedbush PacGrow Healthcare Conference
09/08/2018
ALPHARETTA, Ga., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
09/08/2018
Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT EXTON, Pa., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell [...]
resTORbio Reports Second Quarter 2018 Financial Results
09/08/2018
Phase 2b results identify dose and patient population for pivotal program with RTB101 Initiation of pivotal program with RTB101 expected in the first half of 2019 BOSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc [...]
Progressive Care Announces Pay-Off of Note to Chicago Venture Partners
09/08/2018
MIAMI, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has paid off its convertible note to Chicago Venture [...]
Mustang Bio to Present at 10th Annual Bioprocessing Summit
09/08/2018
NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
HTG Molecular Announces Amendment to Second Statement of Work with QIAGEN Manchester Limited
09/08/2018
TUCSON, Ariz., Aug. 09, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has [...]
Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results
09/08/2018
AUSTIN, Texas, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]
Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update
09/08/2018
CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases [...]
Health Canada Gives Green Light to Tetra Bio-Pharma’s Cannabis Vs. Fentanyl Trial
09/08/2018
Patient recruitment to begin for landmark research ORLEANS, Ontario, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: [...]
Portola Pharmaceuticals Appoints Ernie Meyer as Executive Vice President and Chief Human Resources Officer
09/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced the appointment of Ernie Meyer as executive vice president and chief human resources officer, [...]
Krystal Biotech’s KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis
09/08/2018
PITTSBURGH, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq:KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases [...]
Cocrystal Pharma Reports 2018 Second Quarter Financial Results and Provides Corporate Update
09/08/2018
– First half of 2018 marked by management’s successful execution of corporate, clinical and regulatory strategies – – Topline results from Phase 2a study evaluating CC-31244 for ultra-short treatment of HCV expected in [...]
Precipio Appoints New Board Member to Replace Departing Director
09/08/2018
Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics [...]
Moleculin Seeks Approval from Polish Regulatory Agency for Skin Cancer Clinical Trial
09/08/2018
HOUSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
IMV Inc. Reaches Multiple Milestones in Advanced Ovarian Cancer Clinical Trial
09/08/2018
HALIFAX, Nova Scotia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Enrollment Completed for Phase 1b Cohorts First Dosing Occurred in Phase 2 Portion of the Program IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno- [...]

Pages